FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

19274811000001108: Bydureon 2mg powder and solvent for suspension for injection vials (Eli Lilly and Company Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 27-Jul 2011. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
65302301000001110 Bydureon 2mg powder and solvent for suspension for injection vials (Eli Lilly and Company Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
65302401000001119 Bydureon 2mg powder and solvent for suspension for injection vials (Eli Lilly and Company Ltd) en Synonym Inactive Entire term case sensitive SNOMED CT United Kingdom drug extension module
73581101000001111 Bydureon 2mg powder and solvent for suspension for injection vials (Bristol-Myers Squibb Pharmaceuticals Ltd) en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
80016201000001114 Bydureon 2mg powder and solvent for suspension for injection vials (AstraZeneca UK Ltd) en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
95749801000001117 Bydureon 2mg powder and solvent for suspension for prolonged-release injection vials (AstraZeneca UK Ltd) en Synonym Inactive Only initial character case insensitive SNOMED CT United Kingdom drug extension module
101270401000001116 Bydureon 2mg powder and solvent for prolonged-release suspension for injection vials (AstraZeneca UK Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Bydureon 2mg powder and solvent for suspension for injection vials (Eli Lilly and Company Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Bydureon 2mg powder and solvent for suspension for injection vials (Eli Lilly and Company Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Bydureon 2mg powder and solvent for suspension for injection vials (Eli Lilly and Company Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Bydureon 2mg powder and solvent for suspension for injection vials (Eli Lilly and Company Ltd) Is a Exenatide 2mg powder and solvent for suspension for injection vials true Inferred relationship Existential restriction modifier
Bydureon 2mg powder and solvent for suspension for injection vials (Eli Lilly and Company Ltd) Has active ingredient Exenatide true Inferred relationship Existential restriction modifier
Bydureon 2mg powder and solvent for suspension for injection vials (Eli Lilly and Company Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Bydureon 2mg powder and solvent for suspension for injection vials (Eli Lilly and Company Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Bydureon 2mg powder and solvent for suspension for injection vials (Eli Lilly and Company Ltd) Has specific active ingredient Exenatide true Inferred relationship Existential restriction modifier
Bydureon 2mg powder and solvent for suspension for injection vials (Eli Lilly and Company Ltd) Has dispensed dose form Powder and solvent for suspension for injection false Inferred relationship Existential restriction modifier
Bydureon 2mg powder and solvent for suspension for injection vials (Eli Lilly and Company Ltd) Has excipient Polysorbate false Inferred relationship Existential restriction modifier
Bydureon 2mg powder and solvent for suspension for injection vials (Eli Lilly and Company Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Bydureon 2mg powder and solvent for suspension for injection vials (Eli Lilly and Company Ltd) Is a Bydureon true Inferred relationship Existential restriction modifier
Bydureon 2mg powder and solvent for suspension for injection vials (Eli Lilly and Company Ltd) Has dispensed dose form Powder and solvent for prolonged-release suspension for injection true Inferred relationship Existential restriction modifier
Bydureon 2mg powder and solvent for suspension for injection vials (Eli Lilly and Company Ltd) Has manufactured dose form Powder and solvent for prolonged-release suspension for injection true Inferred relationship Existential restriction modifier
Bydureon 2mg powder and solvent for suspension for injection vials (Eli Lilly and Company Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Bydureon 2mg powder and solvent for suspension for injection vials (Eli Lilly and Company Ltd) 4 vial Has AMP True Bydureon 2mg powder and solvent for suspension for injection vials (Eli Lilly and Company Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start